Successful Treatment of Vitiligo Associated with Vogt-Koyanagi-Harada Disease. Pediatr Dermatol 2017 Mar;34(2):204-205
Date
12/17/2016Pubmed ID
27981622DOI
10.1111/pde.13044Scopus ID
2-s2.0-85006854960 (requires institutional sign-in at Scopus site) 3 CitationsAbstract
Vogt-Koyanagi-Harada disease (VKH) is a rare multisystem disorder with cutaneous, ophthalmic, neurologic, and auditory manifestations. There is a paucity of published literature regarding the management of cutaneous features in VKH. We report a case of VKH-associated vitiligo responsive to topical corticosteroids and topical calcineurin inhibitors.
Author List
Bayer ML, Chiu YEAuthor
Yvonne E. Chiu MD Vice Chair, Professor in the Dermatology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdolescentHumans
Male
Uveomeningoencephalitic Syndrome
Vitiligo